No Data
Disclosure of shareholder equity of Zhikong Hong Kong stocks | April 28
Disclosure of Shareholder equity in Hong Kong stocks | April 28.
Hong Kong Stock Announcement Gold Mining | BYD Company (01211) reported a net income of 9.155 billion yuan in the first quarter, an increase of 100.38% year-on-year.
SIHUAN PHARM (00460): The facial filler (child's face needle) independently developed by Meiyan Space has obtained market approval from the National Medical Products Administration; GRANDPHARMA (00512): The early detection product for urological tumors has achieved its first commercial prescription in mainland China.
The Trump administration plans to impose tariffs on imported Pharmaceuticals, and the U.S. Pharmaceutical Industry warns that it may increase drug costs.
A report commissioned by a trade organization in the USA Pharmaceutical Industry indicates that if the USA imposes a 25% tariff on imported Pharmaceuticals, it could increase the annual Pharmaceutical costs in the USA by nearly 51 billion dollars and raise drug prices by up to 12.9%.
CSPC PHARMA (01093.HK): SYH2068 injection (double-stranded small interfering RNA drug) has received approval for clinical trials.
On April 25, Gelonghui reported that CSPC PHARMA (01093.HK) announced that its independently developed chemical class 1 new drug SYH2068 injection (double-stranded small interfering RNA (si RNA) drug) has been approved by the National Medical Products Administration of China and can carry out clinical trials in China. This product is a si RNA drug that achieves targeted delivery to the liver by conjugating N-acetylgalactosamine (Gal NAc) and targets lipoprotein (a) [Lp(a)] through subcutaneous administration, effectively reducing Lp(a) levels. This product is suitable for the treatment of hyperlipoproteinemia.
CSPC PHARMA (01093): SYH2068 injection (double-stranded small interfering RNA drug) has received approval for clinical trials.
CSPC PHARMA (01093) announced that the Group's independently developed chemical Class 1 new drug SYH2068 injection (...)
CSPC Innovation Pharmaceutical Swings to Q1 Loss
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}